$PRSI
PORTSMOUTH SQUARE INC

2024 Q4 Form 10-Q Financial Statement

#000149315224045042 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $11.82M
YoY Change 6.55%
Cost Of Revenue $8.792M
YoY Change -5.27%
Gross Profit $3.028M
YoY Change 67.11%
Gross Profit Margin 25.62%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses -$9.147M
YoY Change -4.72%
Operating Profit $1.770M
YoY Change 163.39%
Interest Expense $824.0K
YoY Change -137.63%
% of Operating Profit 46.55%
Other Income/Expense, Net -$3.641M
YoY Change 63.2%
Pretax Income -$1.871M
YoY Change 20.01%
Income Tax $1.000K
% Of Pretax Income
Net Earnings -$1.872M
YoY Change 20.0%
Net Earnings / Revenue -15.84%
Basic Earnings Per Share -$2.55
Diluted Earnings Per Share -$2.55
COMMON SHARES
Basic Shares Outstanding 734.2K shares 734.2K shares
Diluted Shares Outstanding 734.2K shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.046M
YoY Change 14.16%
Cash & Equivalents $4.839M
Short-Term Investments $207.0K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $42.84M
YoY Change 0.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $159.7M
YoY Change 7.94%
SHAREHOLDERS EQUITY
Retained Earnings -$119.0M
YoY Change 10.89%
Common Stock $2.092M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$116.9M
YoY Change
Total Liabilities & Shareholders Equity $42.84M
YoY Change 0.16%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.872M
YoY Change 20.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $2.958M
YoY Change 122.07%
INVESTING ACTIVITIES
Capital Expenditures $268.0K
YoY Change -64.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$268.0K
YoY Change -64.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$577.0K
YoY Change -147.33%
NET CHANGE
Cash From Operating Activities $2.958M
Cash From Investing Activities -$268.0K
Cash From Financing Activities -$577.0K
Net Change In Cash $2.113M
YoY Change 17.65%
FREE CASH FLOW
Cash From Operating Activities $2.958M
Capital Expenditures $268.0K
Free Cash Flow $2.690M
YoY Change 366.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90025
CY2024Q3 dei City Area Code
CityAreaCode
(310)
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
889-2500
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
734187 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4839000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3511000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
2049000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
1264000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
606000 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
519000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
707000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
834000 usd
CY2024Q3 us-gaap Assets
Assets
42838000 usd
CY2024Q2 us-gaap Assets
Assets
41402000 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
2404000 usd
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
2388000 usd
CY2024Q3 PRSI Mortgage Notes Payable
MortgageNotesPayable
100546000 usd
CY2024Q2 PRSI Mortgage Notes Payable
MortgageNotesPayable
100783000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
159720000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
156412000 usd
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
734187 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2092000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118974000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117102000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-116882000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-115010000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42838000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11820000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11093000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8792000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9281000 usd
CY2024Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
903000 usd
CY2023Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
821000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
355000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
319000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
10050000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
10421000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1770000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
672000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2824000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1606000 usd
CY2024Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
41000 usd
CY2023Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-88000 usd
CY2024Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4000 usd
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3000 usd
CY2024Q3 PRSI Trading And Margin Interest Expense
TradingAndMarginInterestExpense
38000 usd
CY2023Q3 PRSI Trading And Margin Interest Expense
TradingAndMarginInterestExpense
38000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.12
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.12
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
734187 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
734187 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
734187 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
734187 shares
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-105195000 usd
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000079661
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
usd
CY2024Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
usd
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Entity File Number
EntityFileNumber
0-4057
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
PORTSMOUTH SQUARE, INC.
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-1674111
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1516 S. Bundy Dr.
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
34430000 usd
CY2024Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
35065000 usd
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
207000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
209000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
734187 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
734187 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
734187 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2092000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41402000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-824000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-502000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3641000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2231000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1871000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1559000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1872000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1560000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-115010000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1872000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-116882000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-103635000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-103635000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1560000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-105195000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1872000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-1560000 usd
CY2024Q3 PRSI Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock
MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock
51000 usd
CY2023Q3 PRSI Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock
MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock
-88000 usd
CY2024Q3 PRSI Amortization Of Other Notes Payable
AmortizationOfOtherNotesPayable
-16000 usd
CY2023Q3 PRSI Amortization Of Other Notes Payable
AmortizationOfOtherNotesPayable
141000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
903000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
821000 usd
CY2024Q3 PRSI Amortization Of Loan Costs
AmortizationOfLoanCosts
340000 usd
CY2023Q3 PRSI Amortization Of Loan Costs
AmortizationOfLoanCosts
60000 usd
CY2024Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-53000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
87000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34000 usd
CY2024Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-127000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5000 usd
CY2024Q3 PRSI Increase Decrease In Accounts Payable And Other Liabilities
IncreaseDecreaseInAccountsPayableAndOtherLiabilities
2305000 usd
CY2023Q3 PRSI Increase Decrease In Accounts Payable And Other Liabilities
IncreaseDecreaseInAccountsPayableAndOtherLiabilities
-898000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-439000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2067000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1663000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
924000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2958000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1332000 usd
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
268000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
755000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-268000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-755000 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000 usd
CY2024Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
577000 usd
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
281000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-577000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1219000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2113000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1796000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4775000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5206000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6888000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7002000 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
1035000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
1606000 usd
CY2017Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2017Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
automatically renews for successive one (1) year periods, not to exceed five years in the aggregate, subject to certain conditions
CY2017Q1 PRSI Percentage Of Management Fee Payable
PercentageOfManagementFeePayable
0.0170 pure
CY2017Q1 PRSI Percentage Of Gross Operating Profit
PercentageOfGrossOperatingProfit
0.10 pure
CY2024Q3 PRSI Waive Reduction Amount
WaiveReductionAmount
1030134 usd
CY2024Q3 PRSI Performance Threshold Amount
PerformanceThresholdAmount
15257301 usd
CY2024Q3 PRSI Mortgage Notes Payable
MortgageNotesPayable
100546000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
340000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118974000 usd
CY2013Q4 PRSI Partnership Redemption Adjustment
PartnershipRedemptionAdjustment
64100000 usd
CY2024Q3 PRSI Revenue Per Available Room Rate Description
RevenuePerAvailableRoomRateDescription
the hotel achieved a RevPAR index of 145% while increasing the ADR index to 90%. The Hotel’s year-to-date RevPAR index is 118%. For the quarter ending September 30, 2024, the Hotel gained RevPAR year over year by 5.7% while its Comp Set was -18.5%
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2958000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4839000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3511000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
2049000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
1264000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
207000 usd
CY2024Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
209000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11820000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11093000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
370000 usd
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
337000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
448000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
290000 usd
CY2024Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
102276000 usd
CY2024Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
67846000 usd
CY2024Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
34430000 usd
CY2024Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
102008000 usd
CY2024Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
66943000 usd
CY2024Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
35065000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
903000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
821000 usd
CY2024Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-10000 usd
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
51000 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-88000 usd
CY2024Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
41000 usd
CY2023Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-88000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4839000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3511000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
2049000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
1264000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6888000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4775000 usd
CY2024Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2024Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segments
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11820000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
-9147000 usd
CY2024Q3 PRSI Segment Operating Income Loss
SegmentOperatingIncomeLoss
2673000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2824000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
824000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
903000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1872000 usd
CY2024Q3 us-gaap Assets
Assets
42838000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11093000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
-9600000 usd
CY2023Q3 PRSI Segment Operating Income Loss
SegmentOperatingIncomeLoss
1493000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1606000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
502000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
821000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-123000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-1560000 usd
CY2023Q3 us-gaap Assets
Assets
42771000 usd
CY2017Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P10Y
CY2017Q1 PRSI Key Money Incentive Advance To Related Party
KeyMoneyIncentiveAdvanceToRelatedParty
2000000 usd
CY2017Q1 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P8Y
CY2017Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05275 pure
CY2017Q1 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
Beginning in February 2017, the loan began to amortize over a thirty-year period and matured on January 1, 2024.
CY2024Q3 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
76386000 usd
CY2024Q2 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
76962000 usd
CY2024Q3 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The mezzanine loan is secured by the Operating membership interest held by Mezzanine and is subordinated to the Mortgage Loan. The mezzanine interest only loan had an interest rate of 9.75% per annum and matured on January 1, 2024.
CY2024Q3 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
2451000 usd
CY2024Q2 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
2384000 usd
CY2024Q3 PRSI Advance Deposits
AdvanceDeposits
337000 usd
CY2024Q2 PRSI Advance Deposits
AdvanceDeposits
383000 usd
CY2024Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
527000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
3436000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
3129000 usd
CY2024Q3 PRSI Mortgage Interest Payable
MortgageInterestPayable
5099000 usd
CY2024Q2 PRSI Mortgage Interest Payable
MortgageInterestPayable
3651000 usd
CY2024Q3 PRSI Withholding And Other Taxes Payable
WithholdingAndOtherTaxesPayable
1553000 usd
CY2024Q2 PRSI Withholding And Other Taxes Payable
WithholdingAndOtherTaxesPayable
1382000 usd
CY2024Q3 PRSI Franchise Fee Payable
FranchiseFeePayable
2022000 usd
CY2024Q2 PRSI Franchise Fee Payable
FranchiseFeePayable
1418000 usd
CY2024Q3 us-gaap Management Fee Payable
ManagementFeePayable
1436000 usd
CY2024Q2 us-gaap Management Fee Payable
ManagementFeePayable
2688000 usd
CY2024Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
238000 usd
CY2024Q2 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
198000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
17099000 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
15233000 usd

Files In Submission

Name View Source Status
0001493152-24-045042-index-headers.html Edgar Link pending
0001493152-24-045042-index.html Edgar Link pending
0001493152-24-045042.txt Edgar Link pending
0001493152-24-045042-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
prsi-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
prsi-20240930_cal.xml Edgar Link unprocessable
prsi-20240930_def.xml Edgar Link unprocessable
prsi-20240930_lab.xml Edgar Link unprocessable
prsi-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable